- Home
- MVIS vs MCRB Comparison
MVIS vs MCRB Comparison
Compare MVIS & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | MCRB |
|---|---|---|
| Founded | 1993 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.0M | 41.2M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MVIS | MCRB |
|---|---|---|
| Price | $1.38 | $1.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.3M | 77.8K |
| Earning Date | 10-28-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $664,000.00 | ★ $789,000.00 |
| Revenue This Year | $1,017.55 | N/A |
| Revenue Next Year | $48.15 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $1.68 |
| 52 Week High | $4.90 | $29.98 |
Technical Indicators
Market Signals| Indicator | MVIS | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 21.27 |
| Support Level | $0.56 | N/A |
| Resistance Level | $1.89 | $9.53 |
| Average True Range (ATR) | 0.11 | 0.21 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 67.05 | 9.64 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.